The role of bile acids (BAs) as biomarkers for liver injury has been proposed for decades. However, the large inter-and intraindividual variability of the BA profile has prevented its clinical application. To this end, we investigated the effect of covariates such as food, gender, age, BMI, and moderate alcohol consumption on the BA profile in healthy human subjects. The BA profile was characterized by the calculation of indices that describe the composition, sulfation, and amidation of total and individual BAs. Both inter-and intra-individual variabilities of BA indices were low in serum and even lower in urine compared with those of absolute concentrations of BAs. Serum BA concentrations increased with consumption of food, whereas urinary BA concentrations were mildly affected by food. Gender differences in the urinary and serum BA profile were minimal. The serum and urinary BA profiles were also not affected by age. BMI showed minimal effect on the urine and serum BA profile. Moderate alcohol consumption did not have a significant effect on the BA profile in both urine and serum. When the effect of the type of alcohol was studied, the results indicate that moderate drinking of beer does not affect BA concentrations and has minimal effect on BA indices, whereas moderate wine consumption slightly increases BA concentrations without affecting the BA indices. In summary, urinary BA indices showed lower variability and higher stability than absolute BA concentrations in serum and showed minimal changes to covariate effects suggesting their utility as biomarkers in clinic.
glyco-lithocholic acid-sulfate G-UDCA-S glyco-ursodeoxycholic acid-sulfate G-CDCA-S glyco-chenodeoxycholic acid-sulfate G-DCA-S glyco-deoxycholic acid-sulfate G-CA-S glyco-cholic acid-sulfate T-LCA-S tauro-lithocholic acid-sulfate T-UDCA-S tauro-ursodeoxycholic acid-sulfate T-CDCA-S tauro-chenodeoxycholic acid-sulfate T-DCA-S tauro-deoxycholic acid-sulfate T-CA-S tauro-cholic acid-sulfate Bile acids (BAs) play key roles in many physiological functions such as the elimination of cholesterol, absorption of fat, and regulation of energy expenditure, and glucose and lipid metabolism (Hofmann, 1999; Monte et al., 2009 ). In addition, BAs are cytotoxic at high concentrations and exhibit pathological effects due to their direct detergent effects on biological membranes, apoptotic and necrotic effects via mitochondria and endoplasmic reticulum-mediated toxicities, and cancer promoting effects (Maillette de Buy Wenniger and Beuers, 2010; PauliMagnus and Meier, 2005) . However, individual BAs vary markedly in their physicochemical properties, toxicities, and physiological and pathological effects (Thomas et al., 2008) . Sulfation of BAs is considered the primary detoxification mechanism for the elimination of BAs in humans (Alnouti, 2009 ). Although conflicting reports exist regarding the structure of sulfated BAs, sulfation at 3-OH position is likely to be predominant in humans (Alnouti, 2009) . Sulfation of BAs directly decreases their toxicity, increases their water solubility, and enhances their excretion in urine and feces. In addition, amidation of BAs with glycine and taurine amino acids increases their solubility and reduces their toxicity (Chiang, 2009; Heuman et al., 1991; Thomas et al., 2008) . Therefore, the comprehensive and detailed profiling of total and individual BAs and their sulfated and amidated metabolites is critical to understand the balance between the physiological and pathological effects of BAs in humans and the consequences of disturbing such balance. Cholestatic diseases are hepatobiliary diseases associated with a reduction in bile flow due to defects in bile production or impairment of bile flow through the canaliculi into bile duct. Serum and urine BA levels have been suggested to be used as biomarkers of cholestatic diseases for decades (Huang et al., 2007; Lucangioli et al., 2009; Makino et al., 1975; Muraji et al., 2003; Simko et al., 1987 Simko et al., , 1988 Sinakos and Lindor, 2010; van Berge Henegouwen et al., 1976) . However, this was not translated into the clinic, primarily because of the instability and high variability of serum and urinary BA levels, which precluded the establishment of their normal cut-off values in the absence of liver diseases. There are high intra-individual variations in the BA profile due to numerous factors such as diurnal variation, food ingestion, and medication intake (Duane et al., 1983; Galman et al., 2005; Okolicsanyi et al., 1986; Schalm et al., 1978; Steiner et al., 2011) . In addition, large inter-individual variations in the BA profile in subjects without liver diseases were reported due to gender, alcohol consumption, and obesity (Glicksman et al., 2010; Nestel et al., 1976; Trottier et al., 2011; Xiang et al., 2012) .
The effects of gender, food, age, BMI, and alcohol consumption on the absolute levels of serum BAs were previously reported (Bertolotti et al., 2007; Crouse and Grundy, 1984; Einarsson et al., 1985; Glicksman et al., 2010; Kawasaki et al., 1986; Nestel et al., 1976; Patti et al., 2009; Pikaar et al., 1987; Schalm et al., 1978; Setchell et al., 1982; Steiner et al., 2011; Trottier et al., 2011; Xiang et al., 2012) . In these studies, a relatively small number (4-23 subjects) of subjects were included (Bertolotti et al., 2007; Crouse and Grundy, 1984; Nestel et al., 1976; Pikaar et al., 1987; Schalm et al., 1978; Setchell et al., 1982; ) , only total BAs were studied (Nestel et al., 1976; Pikaar et al., 1987) , and/or many of the major BA species such as the sulfate metabolites were not included (Bertolotti et al., 2007; Crouse and Grundy, 1984; Einarsson et al., 1985; Glicksman et al., 2010; Kawasaki et al., 1986; Nestel et al., 1976; Patti et al., 2009; Pikaar et al., 1987; Schalm et al., 1978; Setchell et al., 1982; Steiner et al., 2011; Trottier et al., 2011; Xiang et al., 2012) . In addition, interand intra-individual variabilities of the detailed BA profile and its metabolites have not been characterized, primarily because of the lack of analytical techniques for the quantification of individual BAs and all their metabolites. This study includes a series of 2 papers, which aim to investigate the use of the BA profile as a biomarker for the diagnosis and prognosis of liver diseases. We use the term "BA profile" to describe any quantitative or qualitative measurement related to BAs. The "BA profile" was characterized using both absolute BA concentrations as well as calculated ratios, which we called "indices". We describe this novel concept of "BA indices", which characterize the BA profile by quantifying the composition, hydrophilicity, and metabolism (including glycine and taurine amidation and sulfation) of total and individual BAs. In this article, we characterized for the first time, the intra-and inter-individual variability and the effect of food, gender, age, BMI, and alcohol consumption on the detailed serum and urinary BA profiles in human subjects without liver diseases. In the second paper of this series, we demonstrated the differences in the urinary BA profiles between healthy subjects and patients with a variety of liver diseases.
MATERIALS AND METHODS
Study participants. In this clinical study, 90 healthy subjects (63 female and 27 male) between the ages of 19 and 65 years were recruited by the Clinical Research Center at the University of Nebraska Medical Center (UNMC). The study was approved by the institutional review board at UNMC and written informed consents were obtained from all participating subjects. Inclusion criteria included the (1) absence of diabetes, (2) normal liver functions, as verified by serum enzymes levels of aspartate aminotransferase <56, alanine aminotransferase <50, and gamma-glutamyltransferase <78, (3) no-or moderate drinking of alcohol, and (4) lack of allergy to the breakfast meal provided in the study. According to the "2010 Dietary Guidelines for Americans" by the Department of Agriculture and the BATHENA ET AL. | 297 Department of Health and Human Services (http://www.cnpp. usda.gov/Publications/DietaryGuidelines/2010/PolicyDoc/ PolicyDoc.pdf), moderate drinking is defined as the consumption of alcoholic beverages up to 1 drink per day for women and up to 2 drinks per day for men. Drinkers were further divided into subjects who consumed beer, wine, or hard liquor. Standard drinks contain the same amount of alcohol and are defined as 12 ounces of beer, 5 ounces of wine, or 1.5 ounces of liquor.
Urine and blood samples were initially collected in the first visit at fasting conditions and 1 h after eating a standard breakfast meal. The standard breakfast included a choice of a chicken, turkey, or veggie quesadilla meal and 240 ml (8 oz) of orange juice. Samples were then collected 1 (second visit), 2 (third visit), and 4 (fourth visit) weeks after the first visit, at fasting conditions. Thirty milliliters of urine and 15 ml of blood were collected from subjects in every visit. All serum and urine samples were stored in À80 C until analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Measurement and calculation of BA indices. More than 45 BAs and their sulfate metabolites were quantified by LC-MS/MS as described previously (Bathena et al., 2013) . A Waters ACQUITY ultra performance liquid chromatography system (Waters, Milford, Massachusetts) coupled to an Applied Biosystem 4000 Q TRAP quadrupole linear ion trap hybrid mass spectrometer with an electrospray ionization source (Applied Biosystems, MDS Sciex, Foster City, California) was used to perform the LC-MS/MS analysis. Serum samples were extracted using protein precipitation with alkaline acetonitrile and urine samples were extracted using solid phase extraction as described previously (Bathena et al., 2013) . The limit of quantification of the method is 1 ng/ml and the method is linear from 1 to 1000 ng/ml. The method was validated and the accuracy and precision were within the acceptable limits. The BA profile was characterized by the calculation of indices that describe the composition, sulfation, and amidation of total and individual BAs ( Table 1 ). The composition indices of individual BAs were calculated as the ratio of the concentration of individual BAs in all of its forms (amidated, unamidated, sulfated, and unsulfated) to the total concentration of BAs. The percentage sulfation of individual BAs was calculated as the ratio of the concentration of sulfated BAs, in both the amidated and unamidated forms, to the total concentration of individual BAs in all of its forms (sulfated, unsulfated, amidated, and unamidated) . The percentage amidation of individual BAs was calculated as the ratio of the concentration of amidated BAs, in both the sulfated and unsulfated forms, to the total concentration of individual BAs in all of its forms (sulfated, unsulfated, amidated, and unamidated) . In addition, percentages of amidation were divided into percentages of BAs existing as glycine-or as taurine-amidates.
Statistical analysis. The effect of food on the BA profile was studied by comparing samples collected at fasting conditions and 1 h after eating the standard meal in the first visit. Even though most of the BA concentrations and indices were not normally distributed (Shapiro-Wilk test), Paired t test was used to study the effect of food because the sample size was more than 30 (Pagano and Gauvreau, 2000) . Fasting samples collected in all 4 visits were used to study the effects of time, gender, age, and alcohol. Mixed effects models with unstructured covariance were used to study the effect of these covariates (Supplementary Table 1 ). Subjects were divided into 4 age groups (19-29, 30-41, 42-53, and 54-65 years) , and the effect of age was studied as both a continuous and a categorical variable using mixed effects models. Subjects were also divided into 3 BMI groups (normal: BMI < 25, overweight: BMI 25-29.9, and obese: BMI ! 30) and the effect of BMI was studied as a categorical variable using mixed effects models. The effect of the type of alcohol (beer and wine) on the BA profile was also studied using mixed effects models. All statistical analysis was performed using the Statistical Product and Service Solutions (SPSS) software, version 18 (IBM corporation, Armonk, NY).
RESULTS
Inter-and Intra-individual Variability of the BA Profile Table 2 lists the average concentrations of the most abundant BAs in urine and serum. The BA profile was characterized via the calculation of BA indices that describe the sulfation, amidation, and composition of total and individual BAs (Table 1) . Figure 1 shows representative absolute concentrations and indices of total and individual BAs in urine and serum over a period of 1 month. Intra-individual variability was studied by monitoring the changes of BAs over time, in the 4 visits, using mixed Tables 2 and 3) . Table 3 shows the relative standard deviation (RSD) of representative absolute concentrations and BA indices in fasting urine and serum. The RSD was calculated by using the fasting samples pooled from 4 visits and reflects the overall inter-and intra-individual variability. In urine, the RSD ranged from 70-140% and 0.6-43% for absolute concentrations and BA indices, respectively. In contrast, the RSD was higher in serum and ranged from 64-242% and 7.5-122%, for absolute concentrations and BA indices, respectively. Table 4 shows the effect of food on representative serum and urinary BAs. As expected, the absolute concentrations of total and individual serum BAs increased (1.2-to 1.7-fold) after eating a meal. The percentage sulfation of total and individual BAs in serum decreased slightly (approximately 0.7-to 0.9-fold), whereas the percentage amidation of total and individual BAs increased slightly (1.1-to 1.3-fold) after meal. In contrast to serum BAs, the absolute concentrations of total and individual BATHENA ET AL. | 299 urinary BAs slightly decreased with food (approximately 0.7-to 0.9-fold). For example, unsulfated chenodeoxycholic acid (CDCA) was significantly higher in serum (2-fold) after food intake (P < 0.05), whereas this effect was not observed in urine (Fig. 2) . In addition, BA indices in urine, including percentage sulfation and percentage amidation were almost completely resistant to any food effects (Table 4 and Fig. 2 ). Similar to the sulfation and amidation indices, the percentage composition of the BA profile in serum was slightly affected (0.8-fold for ursodeoxycholic acid [UDCA] and 1.1-to 1.2-fold higher for cholic acid [CA] and CDCA) by food, while the same indices in urine were resistant to any changes.
Food Effect

Gender Effect on BAs
All BA concentrations and indices that demonstrated statistically significant gender differences using mixed effects modeling are marked in Supplementary Table 2 (in urine) and Supplementary Table 3 (in serum). Table 5 compares the values of representative urinary and serum BA concentrations and indices between males and females. The absolute concentrations of urinary total BAs and sulfated BAs were generally similar between males and females except for tauro-chenodeoxycholic acid (T-CDCA) (3.4-fold), CA (3.1-fold), lithocholic acid (LCA) (2.8-fold), and glyco-chenodeoxycholic acid (G-CDCA) (2.0-fold), which were higher in males; whereas 12-oxo-LCA (5.8-fold) and 7-oxo-LCA (2-fold) were higher in females and yet none of them were statistically significant. The percentage sulfation of overall BAs (0.95-fold) and CA (0.7-fold) were lower in males, whereas no gender differences were observed in the percentage sulfation of other individual BAs. The percentage amidation of CA was lower in males (0.8-fold), whereas no gender differences were observed in the percentage amidation of total or other individual BAs. There were also no gender differences in the percentage composition of individual BAs in urine. The absolute concentrations of serum total, sulfated, and unsulfated BAs were similar in males and females. However, few individual BAs such as nor-deoxycholic acid (norDCA) were higher in males (2.0-fold), whereas cholic acid-sulfate (CA-S) (4-fold), tauro-cholic acid (T-CA) (3.7-fold), and tauro-ursodeoxycholic acid (T-UDCA) (2-fold) were higher in females. The percentage sulfation of total and individual BAs in serum was similar between males and females except for the percentage sulfation of CA and UDCA, which were 0.6-fold lower and 1.2-fold higher in males, respectively. The percentage amidation of overall BAs in serum was also similar between males and females except for the percentage amidation of CA and UDCA, which were 0.8-fold lower and 1.1-fold higher in males, respectively. Similarly, there were no gender differences in the percentage composition of individual BAs.
Effect of Age
The absolutes levels of BAs in urine and serum did not vary with age whether age was included as a continuous or categorical variable in the statistical analysis (data not shown). Similar to the absolute concentrations, the urinary and serum BA indices did not show statistically significant difference with age. However, few BA indices demonstrated significant differences between the age groups only when age was studied as a categorical rather than a continuous variable (Supplementary  Tables 2 and 3 ). Table 6 compares representative urinary and serum BA concentrations and indices between the 3 BMI groups. The absolute levels of BAs in urine and serum were similar in all 3 BMI groups (Table 6; Supplementary Tables 2 and 3 ). The percentage sulfation of total and individual BAs in urine and serum was not affected by BMI, except for the percentage sulfation of CA, which was 0.5-and 0.6-fold lower in the serum of overweight and obese groups, respectively, compared with normal group. In urine, the percentage amidation of DCA was slightly lower (approximately 0.99-fold) in the obese group compared with normal and overweight groups, and the percentage amidation of CA was slightly lower in obese group (0.8-fold) than normal group, whereas the percentage amidation of overall and other BAs was not affected by BMI. In serum, the percentage amidation of CDCA and CA was lower by 0.9-fold and 0.8-fold in obese and overweight groups, respectively, compared with normal group. The percentage composition of BAs in urine and serum was not affected by BMI, except for the percentage total DCA, which was 0.8-fold lower in overweight and obese groups compared with normal group. Table 7 summarizes the effect of moderate alcohol drinking on representative BA concentrations and indices in urine and serum. When the effect of moderate alcohol drinking was studied by categorizing the subjects into 2 groups irrespective of the type of alcohol consumed (drinking vs no-drinking groups), there were no statistically significant effects of alcohol on either the total, individual BAs, or BA indices including percentage sulfation, percentage amidation, and percentage composition in both urine and serum. In comparison to nondrinkers, total and individual BAs were generally lower in beer drinkers and higher in wine drinkers in both urine and serum. The percentage sulfation of total and individual BAs in urine and serum were not affected by either beer or wine, except for the percentage sulfation of CA, which a Ratio of the mean of males to females. b Statistically significant (P < 0.05) using mixed effects models.
Effect of BMI
Effect of Moderate Alcohol Drinking
BATHENA ET AL. | 301 was 1.4-fold higher in the serum of wine drinkers. There was a significant decrease in the percentage amidation of total BAs (approximately 0.9-fold) in urine and CA (approximately 0.9-fold) in urine and serum of the beer drinkers, whereas the percentage amidation of other individual BAs was minimally affected by beer. In contrast to the beer drinkers, the percentage amidation of total and individual BAs was similar in the wine drinkers compared with the nondrinkers in both urine and serum. The percentage composition of BAs in serum was not affected significantly by beer, whereas an increase in the percentage of LCA (1.3-fold) and CA (1.2-fold), and a decrease in the percentage of CDCA (approximately 0.8-fold) in urine were observed in beer drinkers. The percentage composition of BAs in both urine and serum was not affected by wine.
DISCUSSION
We have recently characterized the detailed BA profile in serum and urine of humans without liver diseases (Bathena et al., 2013) . In order to study how the profile of BAs changes over time, fasting samples collected from 90 healthy subjects in 4 visits over a period of 1 month were analyzed using mixed effects modeling. Samples collected post-meal were excluded because of the well-established effect of food on BAs. The averages of the absolute BA concentrations and BA indices did not change over time (ie, low intra-individual variability) in the 4 visits ( Fig. 1; Supplementary Tables 2 and 3 ). Because the intraindividual variations were minimal (Fig. 1) , the large RSD values shown for some BAs in Table 3 are dominated by the inter-individual variability. This inter-individual variability of the absolute BA concentrations was higher (as high as 242% RSD) than that of the BA indices (as low as 0.6% RSD) in both urine and serum ( Fig. 1 and Table 3 ). A significant positive correlation (P < 0.05) was found between serum and urine BA profile (data not shown). However, the inter-and intra-individual variabilities of urinary BA indices were much smaller than that in serum. For example, the RSD of percentage sulfation of overall BAs was 8% and 47% in urine and serum, respectively. Therefore, we have demonstrated that BA indices are more stable and less variable than absolute BA concentrations, which may facilitate their clinical application as a biomarker for hepatobiliary diseases.
Results from our study indicate that serum BAs were increased up to 1.7-fold after eating a meal (Table 4) . Serum BA levels usually rise after food ingestion due to the release of cholecystokinin, which stimulates gallbladder contraction resulting in increasing bile flow into the intestine. Previous studies also reported a significant increase in serum BAs after eating a meal (Angelin and Bjö rkhem, 1977; Schalm et al., 1978; Setchell et al., 1982; Steiner et al., 2011) . In contrast to absolute concentrations, serum BA indices were moderately affected by consumption of food in our study (up to 30%). Also, in the current study, food did not have any effect on the urinary BA indices, whereas a decrease in the absolute concentrations of urinary BAs was observed with food ( Fig. 2 and Table 4 ). Urinary BAs were also previously shown to be moderately affected by meals compared Significant difference between normal and overweight/obese groups using mixed effects models b Significant difference between overweight and obese groups using mixed effects models with serum BAs (Simko et al., 1987; Simko and Michael, 1998) . Collectively, our data show that food has a stronger effect on the serum BA profile than the urinary BA profile. Therefore, the serum BA profile should be obtained at fasting conditions to avoid any meal effects. In contrast, the urinary BA profile, especially BA indices, can be used regardless of the feeding status.
There were no significant gender differences in the absolute levels of serum or urinary BAs in our study (Table 5) . Several studies reported the absence of gender differences in the absolute levels of BAs (Barbara et al., 1980; Hofmann et al., 1982; Kawasaki et al., 1986; Shaffer and Gordon, 1978; Starkey and Marks, 1982; Steiner et al., 2011) . In contrast, few studies reported significantly higher levels of specific BAs such as serum unsulfated CA, UDCA, CDCA, DCA, unamidated Bas, and total unsulfated BAs in males compared with females (Trottier et al., 2011; Xiang et al., 2012) . The slight gender difference (5%) in BA sulfates we are reporting may be due to gender differences in sulfotransferases (SULTs) activity and expression since higher Sult mRNA and protein levels in mice and rats females were reported previously (Alnouti and Klaassen, 2006; Alnouti and Klaassen, 2008; Alnouti, 2009; Barnes et al., 1979a,b; Chen et al., 1995; Dunn and Klaassen, 1998; Hammerman et al., 1978) . In contrast, protein expression and activity of the enzyme responsible for BA amidation, BA coenzyme A:amino acid N-acyltransferase, was previously reported to be similar in male and female rat livers (Styles et al., 2007) . These reports are in agreement with the results from our study, which suggest that percentage amidation of overall BAs does not vary between males and females (Table 5) . Overall, our results suggest that no gender differences in the urinary and serum BA profile exist in humans except for slightly higher BA sulfates in females compared with males.
There was no significant effect of age on either the serum or the urinary BA profiles (Supplementary Tables 2 and 3 ). The age effect on BAs was also not observed in previous reports (Kawasaki et al., 1986; Steiner et al., 2011) . However, others reported that cholesterol 7-alpha hydroxylation, the rate-limiting step in BA synthesis, decreased with age (Bertolotti et al., 2007; Einarsson et al., 1985) . In addition, the concentration of total serum BAs is usually high in infants with peak levels occurring between 6 days and 1 month after birth. The total serum BA concentration then decreases with age and reaches to adult BA levels in children at 4-6 years of age (Kawasaki et al., 1986) .
No significant effect of BMI was observed on either the absolute levels of urine or serum BAs (Table 6; Supplementary  Tables 2 and 3 ) in our study. The effect of BMI was also not observed on fasting serum BAs in previous reports although a decrease in postprandial BA levels was seen in obese subjects compared with normal weight subjects (Glicksman et al., 2010; Patti et al., 2009) . There was no effect of BMI on the percentage sulfation or percentage amidation of total BAs in either urine or serum, whereas BMI demonstrated minimal effect on percentage amidation of few individual BAs especially in urine compared with serum (Supplementary Tables 2 and 3 ). The composition of BAs was generally resistant to the changes in BMI.
The urinary and serum BA profiles were not affected by moderate alcohol drinking in the current study (Table 7) . Previous reports also indicated that moderate alcohol consumption did not affect the absolute concentrations of BAs (Crouse and Grundy, 1984; Pikaar et al., 1987) . On the other hand, the effects of chronic alcohol consumption and alcoholic liver diseases on the BA profile are well established. Studies by Kerai et al. (1998 Kerai et al. ( , 2001 ) indicated that chronic alcohol consumption increased serum BA levels in rats. The increase in serum BA concentrations demonstrated in patients with alcoholic liver diseases (Fischer et al., 1996; Islam et al., 1985; Joelsson et al., 1984; Jonsson et al., 1992; Mannes et al., 1982; Milstein et al., 1976; Poupon et al., 1981; Tobiasson and Boeryd, 1980; Trinchet et al., 1994; ) suggest that BAs are involved in the alcohol-induced liver toxicity. The increases in serum BA levels in patients with liver diseases were predominated by CDCA in alcoholic liver diseases, whereas CA dominated the BA pool in chronic cholestatic diseases (Pennington et al., 1977; Tobiasson and Boeryd, 1980) . It should be noted that we only had moderate drinkers enrolled in this study, which did not seem to have a significant effect on the BA profile.
The effect of the type of alcohol on the BA profile was also investigated (Table 7) . Among the 57 drinkers in the study, 20 subjects consumed beer alone, 12 subjects consumed wine alone, 2 subjects consumed liquor alone, and the remaining 23 subjects consumed a combination of 2 or 3 types of alcohol. The effect of beer and wine on the BA profile was studied by comparing beer or wine drinkers with nondrinkers, separately. The effect of liquor on BA profile could not be studied, as there were only 2 subjects who consumed liquor alone. Results from our study indicate that moderate drinking of beer has no effect on BA concentrations and demonstrated minimal effect on BA indices, whereas moderate wine consumption slightly increased BA concentrations without affecting the BA indices (Table 7) .
The limitations of the current study include: (1) the established effect of diurnal rhythm on BAs (Galman et al., 2005; Schalm et al., 1978; Steiner et al., 2011) was not investigated. However, in contrast to the absolute concentrations of BAs, we speculate that BA indices would be resistant to the effects of diurnal rhythm as these are ratios. (2) The number of subjects based on gender was unbalanced in the current study (63 female and 27 male). (3) We did not investigate the effect of race on the BA profile. All these limitations will be addressed over time as recruitment continues for this study.
In summary, inter-and intra-individual variability of BA indices were low in serum and even lower in urine compared with absolute BA concentrations. Food demonstrated a stronger effect on the serum than the urinary BA profiles indicating that serum BA profile should be obtained at fasting conditions, whereas the urinary BA profile, especially BA indices, can be used regardless of the feeding status. Gender differences in the urinary and serum BA profile do not exist in humans except for slightly higher BA sulfates in females compared with males. Age also did not have a significant effect on either the urinary or the serum BA profiles. BMI showed minimal effect on the urine and serum BA profile. Moderate drinking of beer has no effect on BA concentrations and demonstrated minimal effect on BA indices, whereas moderate wine consumption slightly increased BA concentrations without affecting the BA indices. Overall, in contrast to absolute BA concentrations, several BA indices demonstrated low intraand inter-individual variability and were resistant to covariate effects including age, gender, BMI, and moderate alcohol consumption. The urinary BA indices demonstrated minimal inter-and intra-individual variability and were minimally affected by food compared with the same indices in serum. This suggests that urinary BA indices have a better potential than the absolute urine or serum BA concentrations as biomarkers for hepatobiliary diseases in the clinic. The potential role of the most stable BA indices as diagnostic and prognostic biomarkers to predict the risk, severity, and outcomes of liver diseases in humans is illustrated in a pilot study in the second paper of this series.
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